Literature DB >> 16192615

Apoptosis induction by trastuzumab: possible role of the core biopsy intervention.

Sylvie Ménard, Serenella M Pupa, Manuela Campiglio, Manuella Campiglio, Andrea Balsari, Francesco Fagnoni, Alberto Costa, Elda Tagliabue, Elda Taglibue.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16192615     DOI： 10.1200/JCO.2005.02.4679

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

Review 1.  The ErbB2 signaling network as a target for breast cancer therapy.

Authors:  Ali Badache; Anthony Gonçalves
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-01       Impact factor: 2.673

2.  Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer.

Authors:  Holbrook E Kohrt; Roch Houot; Kipp Weiskopf; Matthew J Goldstein; Ferenc Scheeren; Debra Czerwinski; A Dimitrios Colevas; Wen-Kai Weng; Michael F Clarke; Robert W Carlson; Frank E Stockdale; Joseph A Mollick; Lieping Chen; Ronald Levy
Journal:  J Clin Invest       Date:  2012-02-13       Impact factor: 14.808

3.  Targeting HER2 in breast cancer: overview of long-term experience.

Authors:  Evan Lantz; Ivan Cunningham; Gerald M Higa
Journal:  Int J Womens Health       Date:  2010-08-09

4.  Comparison of gene expression profiles in core biopsies and corresponding surgical breast cancer samples.

Authors:  Rosanna Zanetti-Dällenbach; Vincent Vuaroqueaux; Edward Wight; Martin Labuhn; Gad Singer; Patrick Urban; Urs Eppenberger; Wolfgang Holzgreve; Serenella Eppenberger-Castori
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

5.  KIR Genes and Their Ligands Predict the Response to Anti-EGFR Monoclonal Antibodies in Solid Tumors.

Authors:  Cristina Morales-Estevez; Juan De la Haba-Rodriguez; Barbara Manzanares-Martin; Ignacio Porras-Quintela; Antonio Rodriguez-Ariza; Alberto Moreno-Vega; Maria J Ortiz-Morales; Maria A Gomez-España; Maria T Cano-Osuna; Javier Lopez-Gonzalez; Beatriz Chia-Delgado; Rafael Gonzalez-Fernandez; Enrique Aranda-Aguilar
Journal:  Front Immunol       Date:  2016-12-05       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.